Baird Medical Investment Holdings Limited (BDMD)
NASDAQ: BDMD · Real-Time Price · USD
1.790
+0.070 (4.07%)
May 1, 2026, 4:00 PM EDT - Market closed

BDMD Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
22.5437.0431.4635.0929.7
Revenue Growth (YoY)
-39.15%17.73%-10.35%18.16%63.92%
Cost of Revenue
3.654.384.237.055.03
Gross Profit
18.8832.6527.2328.0424.67
Selling, General & Admin
24.3811.1611.0910.558.64
Research & Development
20.136.174.273.861.54
Other Operating Expenses
----0.31
Operating Expenses
44.5117.3415.3714.4110.07
Operating Income
-25.6315.3211.8613.6314.6
Interest Expense
-0.74-0.58-0.29-0.3-0.15
Interest & Investment Income
0000.010
Currency Exchange Gain (Loss)
----0.05
Other Non Operating Income (Expenses)
-0.01-0.650.781.18-0.98
EBT Excluding Unusual Items
-26.3714.0912.3614.5213.52
Other Unusual Items
----0.79
Pretax Income
-26.3714.0912.3614.5214.32
Income Tax Expense
1.171.491.71.752.53
Earnings From Continuing Operations
-27.5412.610.6612.7711.78
Minority Interest in Earnings
0.26-0.14-0.11-0.21-0.1
Net Income
-27.2812.4510.5512.5711.68
Net Income to Common
-27.2812.4510.5512.5711.68
Net Income Growth
-18.09%-16.09%7.60%64.54%
Shares Outstanding (Basic)
282221261,181
Shares Outstanding (Diluted)
282221261,181
Shares Change (YoY)
27.33%5.55%-19.08%-97.84%-
EPS (Basic)
-0.980.570.510.490.01
EPS (Diluted)
-0.980.570.510.490.01
EPS Growth
-11.77%4.08%4853.49%-
Free Cash Flow
-1.39-9.17-3.66-5.425.92
Free Cash Flow Per Share
-0.05-0.42-0.18-0.210.01
Gross Margin
83.79%88.17%86.56%79.90%83.08%
Operating Margin
-113.73%41.35%37.71%38.85%49.16%
Profit Margin
-121.04%33.62%33.52%35.82%39.33%
Free Cash Flow Margin
-6.15%-24.75%-11.63%-15.46%19.95%
EBITDA
-24.5316.4512.8814.5515.42
EBITDA Margin
-108.83%44.43%40.93%41.46%51.91%
D&A For EBITDA
1.11.141.010.920.82
EBIT
-25.6315.3211.8613.6314.6
EBIT Margin
-113.73%41.35%37.71%38.85%49.16%
Effective Tax Rate
-10.57%13.76%12.03%17.69%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q